Clinical Trials Browser

Completed × Recurrence × etoposide phosphate × Clear all

NCT01411267 2022-04-04

AC220 for Children With Relapsed/Refractory ALL or AML

Phase 1 Completed

24 enrolled 14 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00070187 2013-10-17

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Phase 2/3 Completed

Hodgkin Disease, Lymphoma, Recurrence